Frequently Asked Questions

Navigating drug development is complex—we're here to simplify it. This FAQ section addresses key questions from biotech sponsors about our model, timelines, regulatory strategy, and how we help accelerate your asset from concept to commercialization.

  • What are the key stages of drug development?

    The drug development process involves several stages, from initial research (Discovery) and non-clinical/preclinical testing to clinical trials (Phases I-III) and regulatory approval, and lastly post-marketing (Phase IV). VJO Canada helps streamline this process, ensuring that each phase is optimized for success.

  • What is the typical timeline from discovery to IND (Investigational New Drug)?

    The typical timeline for drug development from discovery to IND (Investigational New Drug) submission is approximately 18 to 36 months, depending on the complexity of the program and therapeutic area. This includes lead candidate selection, nonclinical safety studies, pharmacology, toxicology, formulation development, and the compilation of data into regulatory-ready documents. Strategic planning and proactive project management can streamline this timeline by identifying risks early and aligning studies to meet regulatory requirements efficiently.



  • When should I engage a regulatory consultant or project manager?

    Ideally early— once you've found your target compound, prior to key animal studies. Before initiating POC/PD studies is key to guide planning, vendor selection, and documentation for the road ahead. 

  • What services does VJO Canada offer?

    VJO Canada provides comprehensive drug development consulting services, including regulatory affairs, non-clinical support, and general consulting tailored to the needs of biotech companies at every stage of their development process.

  • How does VJO Canada support biotech companies?

    We partner with biotech companies to navigate the complexities of drug development, offering expertise in project management, regulatory compliance, and strategic planning to ensure successful outcomes and efficient exit strategies.

  • How can I get started with VJO Canada?

    Getting started is easy! Contact us for a personalized consultation, and we will discuss your specific needs and how we can assist you in achieving your drug development goals.

  • What types of funding strategies does VJO Canada support?

    Dilutive and non-dilutive funding, in-licensing, partnerships, and technology transfer readiness.

VJO's Innovative Drug Development Methodology

A circle with the words vj8 canada on it
At VJO Canada, we redefine drug development through our unique reverse engineering approach. By starting with your end goals, we tailor the entire research process to ensure efficiency and effectiveness, aligning every step with your exit strategy.
Our methodology emphasizes project optimization, allowing us to streamline operations and reduce costs while maintaining high standards of quality. This strategic focus not only accelerates timelines but also enhances the potential for successful outcomes in drug development.

VJO Canada’s reverse engineering strategy transforms your vision into reality, ensuring a clear path from concept to market.

Get in Touch

Ready to accelerate your novel drug development?


Contact us today for a personalized consultation tailored to your needs.